Glucocorticoid receptor gene haplotype structure and steroid therapy outcome in IBD patients

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 31

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

501

HTML

3347

Figures (1-6)

260

Tables (1-8)

191

Sum=4299

Aug 21, 2010 (publication date) through Nov 24, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastroenterol. Aug 21, 2010; 16(31): 3888-3896
Published online Aug 21, 2010. doi: 10.3748/wjg.v16.i31.3888

Table 6 Extraintestinal manifestations

Extraintestinal manifestations	n (%)¹
Peripheral arthritis	46 (27.2)
Uveitis/iritis	6 (3.6)
Pyoderma gangrenosum	4 (2.4)
Erythema nodosum	9 (5.3)
Aphthous oral ulcers	10 (5.9)
Ankylosing spondylitis	7 (4.1)
Primary sclerosing cholangitis	6 (3.6)

¹Documented for 169 patients.

Citation: Mwinyi J, Wenger C, Eloranta JJ, Kullak-Ublick GA. Glucocorticoid receptor gene haplotype structure and steroid therapy outcome in IBD patients. World J Gastroenterol 2010; 16(31): 3888-3896
URL: https://www.wjgnet.com/1007-9327/full/v16/i31/3888.htm
DOI: https://dx.doi.org/10.3748/wjg.v16.i31.3888